- Home
- POCI vs ESLA Comparison
POCI vs ESLA Comparison
Compare POCI & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POCI
- ESLA
- Stock Information
- Founded
- POCI 1982
- ESLA 2021
- Country
- POCI United States
- ESLA United States
- Employees
- POCI N/A
- ESLA N/A
- Industry
- POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- POCI Health Care
- ESLA Health Care
- Exchange
- POCI Nasdaq
- ESLA Nasdaq
- Market Cap
- POCI 32.4M
- ESLA 35.5M
- IPO Year
- POCI N/A
- ESLA N/A
- Fundamental
- Price
- POCI $4.78
- ESLA $0.99
- Analyst Decision
- POCI
- ESLA Strong Buy
- Analyst Count
- POCI 0
- ESLA 1
- Target Price
- POCI N/A
- ESLA $16.00
- AVG Volume (30 Days)
- POCI 13.9K
- ESLA 519.8K
- Earning Date
- POCI 05-15-2025
- ESLA 05-14-2025
- Dividend Yield
- POCI N/A
- ESLA N/A
- EPS Growth
- POCI N/A
- ESLA N/A
- EPS
- POCI N/A
- ESLA N/A
- Revenue
- POCI $17,626,155.00
- ESLA N/A
- Revenue This Year
- POCI N/A
- ESLA $101.09
- Revenue Next Year
- POCI N/A
- ESLA N/A
- P/E Ratio
- POCI N/A
- ESLA N/A
- Revenue Growth
- POCI N/A
- ESLA N/A
- 52 Week Low
- POCI $3.47
- ESLA $0.63
- 52 Week High
- POCI $6.59
- ESLA $3.23
- Technical
- Relative Strength Index (RSI)
- POCI 56.46
- ESLA 50.39
- Support Level
- POCI $4.47
- ESLA $0.94
- Resistance Level
- POCI $4.80
- ESLA $1.02
- Average True Range (ATR)
- POCI 0.28
- ESLA 0.12
- MACD
- POCI 0.00
- ESLA -0.01
- Stochastic Oscillator
- POCI 85.11
- ESLA 52.50
About POCI Precision Optics Corporation Inc.
Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.